|
|
Home Page What's New
June 10, 2008
"AMCP Objects to Section 176 of Senate Medicare Bill Requiring Formulary Inclusion of Essentially All Drugs in Specified Classes"
The Academy of Managed Care Pharmacy (AMCP) strongly objects to Section 176 of S. 3101, the "Medicare Improvements for Patients and Providers Act of 2008" introduced on June 6 by Senator Baucus, chairman of the Senate Committee on Finance. The provision, “Formulary Requirements with Respect to Certain Categories or Classes of Drugs,” would require the Department of Health and Human Services:
- to identify classes of drugs used to treat major or life threatening conditions where access to multiple drugs in that class due to unique chemical actions and pharmacological effects is required
- to require formularies of Medicare Part D drug plan sponsors to include “all or substantially all” drugs in the classes that are identified
AMCP believes this provision would undermine the current process mandated by the Medicare Modernization Act by which drugs are evaluated for clinical effectiveness and safety. We also believe this provision is unnecessary and inconsistent with the competitive structure that forms the foundation of the Part D benefit.
To read the full substance of the letter, please click here.
|
|
|
|
|
|
Join AMCP on 
Join AMCP on 
Follow AMCP on 
AMCP RESOURCES
Advocacy
JMCP
Practice Resources
Get Connected
Get Involved
|
|
.jpg)
